التفاصيل البيبلوغرافية
| العنوان: |
Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type. |
| المؤلفون: |
Franceschi, Roberto, Pertile, Riccardo, Marigliano, Marco, Mozzillo, Enza, Maffeis, Claudio, Morotti, Elisa, Di Candia, Francesca, Fedi, Ludovica, Iafusco, Dario, Zanfardino, Angela, Cauvin, Vittoria, Maltoni, Giulio, Zucchini, Stefano, Cherubini, Valentino, Tiberi, Valentina, Minuto, Nicola, Bassi, Marta, Rabbone, Ivana, Savastio, Silvia, Tinti, Davide |
| المصدر: |
Diabetic Medicine; Jun2024, Vol. 41 Issue 6, p1-9, 9p |
| مصطلحات موضوعية: |
TYPE 1 diabetes, PARENTS, STATISTICAL correlation, CROSS-sectional method, SATISFACTION, GLYCEMIC control, QUESTIONNAIRES, CAREGIVERS, CONTINUOUS glucose monitoring, QUALITY of life, RESEARCH, PATIENT satisfaction, PATIENTS' attitudes, WELL-being, MEDICAL practice |
| مستخلص: |
Aims: While continuous glucose monitoring (CGM) and associated technologies have positive effects on metabolic control in young people with type 1 diabetes (T1D), less is known about their impact on quality of life (QoL). Here, we quantified CGM satisfaction and QoL in young people with T1D and their parents/caregivers to establish (i) the relationship between QoL and CGM satisfaction and (ii) the impact of the treatment regimen on QoL. Methods: This was a cross‐sectional study of children and adolescents with T1D on different treatment regimens (multiple daily injections, sensor‐augmented pumps and automated insulin delivery). QoL was assessed with the KINDL instrument, and CGM satisfaction with the CGM‐SAT questionnaire was evaluated in both youths with T1D and their parents. Results: Two hundred and ten consecutively enrolled youths with T1D completed the KINDL and CGM‐SAT questionnaires. The mean total KINDL score was greater than neutral in both subjects with T1D (3.99 ± 0.47) and parents (4.06 ± 0.40), and lower overall CGM‐SAT scores (i.e., higher satisfaction) were significantly associated with higher QoL in all six KINDL subscales (p < 0.05). There were no differences in KINDL scores according to delivery technology or when participants were grouped according to optimal and sub‐optimal glucose control. Conclusions: Higher satisfaction with recent CGMs was associated with better QoL in all dimensions. QoL was independent of both the insulin delivery technology and glycaemic control. CGM must be further disseminated. Attention on perceived satisfaction with CGM should be incorporated with the clinical practice to improve the well‐being of children and adolescents with T1D and their families. [ABSTRACT FROM AUTHOR] |
|
Copyright of Diabetic Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
